Alkyl Amines Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 26, 2026, 3:05 am

Market Cap	7,049 Cr.
Current Price	1,378
Intrinsic Value	₹1,187.27
High / Low	2,449/1,212
Stock P/E	39.0
Book Value	282
Dividend Yield	0.73 %
ROCE	18.7 %
ROE	14.0 %
Face Value	2.00
PEG Ratio	-9.05

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Alkyl Amines Chemicals Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Alkyl Amines Chemicals Ltd	7,049 Cr.	1,378	2,449/1,212	39.0	282	0.73 %	18.7 %	14.0 %	2.00
Elantas Beck India Ltd	6,214 Cr.	7,838	14,250/7,111	42.0	1,272	0.10 %	21.2 %	15.8 %	10.0
Foseco India Ltd	3,806 Cr.	5,050	6,846/3,251	46.4	1,379	0.50 %	16.3 %	11.9 %	10.0
Balaji Amines Ltd	3,433 Cr.	1,060	1,946/905	23.8	581	1.04 %	11.0 %	8.83 %	2.00
Fine Organic Industries Ltd	12,974 Cr.	4,232	5,494/3,355	33.1	808	0.26 %	26.4 %	19.5 %	5.00
Industry Average	4,203.75 Cr	1,361.43		140.90	384.56	0.49%	13.78%	9.96%	7.56

All Competitor Stocks of Alkyl Amines Chemicals Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	388	412	410	352	322	357	400	415	371	386	406	389	354
Expenses	319	335	336	304	262	288	321	341	301	318	329	319	287
Operating Profit	70	78	74	48	60	69	79	74	71	68	77	70	67
OPM %	18%	19%	18%	14%	19%	19%	20%	18%	19%	18%	19%	18%	19%
Other Income	5	2	5	2	5	3	5	9	7	9	8	7	8
Interest	1	1	1	2	1	1	0	0	0	0	0	0	0
Depreciation	11	12	12	13	17	17	18	18	18	18	18	18	18
Profit before tax	63	67	66	36	46	53	66	64	59	59	66	59	57
Tax %	27%	28%	25%	25%	28%	28%	26%	26%	26%	22%	25%	27%	26%
Net Profit	46	49	50	27	33	38	49	47	44	46	49	43	42
EPS in Rs	8.94	9.52	9.74	5.33	6.54	7.52	9.56	9.28	8.56	9.00	9.67	8.40	8.26

Last Updated: February 6, 2026, 7:18 pm

Below is a detailed analysis of the quarterly data for Alkyl Amines Chemicals Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

For Sales, as of Dec 2025, the value is 354.00 Cr.. The value appears to be declining and may need further review. It has decreased from 389.00 Cr. (Sep 2025) to 354.00 Cr., marking a decrease of 35.00 Cr..
For Expenses, as of Dec 2025, the value is 287.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 319.00 Cr. (Sep 2025) to 287.00 Cr., marking a decrease of 32.00 Cr..
For Operating Profit, as of Dec 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Sep 2025) to 67.00 Cr., marking a decrease of 3.00 Cr..
For OPM %, as of Dec 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Sep 2025) to 19.00%, marking an increase of 1.00%.
For Other Income, as of Dec 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Sep 2025) to 8.00 Cr., marking an increase of 1.00 Cr..
For Interest, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
For Depreciation, as of Dec 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 18.00 Cr..
For Profit before tax, as of Dec 2025, the value is 57.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Sep 2025) to 57.00 Cr., marking a decrease of 2.00 Cr..
For Tax %, as of Dec 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2025) to 26.00%, marking a decrease of 1.00%.
For Net Profit, as of Dec 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Sep 2025) to 42.00 Cr., marking a decrease of 1.00 Cr..
For EPS in Rs, as of Dec 2025, the value is 8.26. The value appears to be declining and may need further review. It has decreased from 8.40 (Sep 2025) to 8.26, marking a decrease of 0.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 18, 2026, 6:16 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	446	476	484	501	616	846	993	1,242	1,542	1,683	1,441	1,572	1,535
Expenses	362	390	393	405	499	682	736	812	1,216	1,335	1,189	1,280	1,253
Operating Profit	85	87	91	95	118	164	257	430	326	348	252	291	282
OPM %	19%	18%	19%	19%	19%	19%	26%	35%	21%	21%	17%	19%	18%
Other Income	2	2	2	1	2	4	40	6	14	9	14	30	33
Interest	12	10	8	8	8	15	10	6	3	3	4	1	1
Depreciation	10	11	13	14	16	23	27	29	35	45	59	71	71
Profit before tax	65	67	72	74	96	130	260	401	302	309	202	249	242
Tax %	34%	32%	31%	32%	33%	36%	17%	26%	26%	26%	26%	25%
Net Profit	43	45	50	50	64	84	215	295	225	229	149	186	181
EPS in Rs	8.41	8.91	9.77	9.87	12.61	16.42	42.21	57.91	44.04	44.75	29.12	36.39	35.33
Dividend Payout %	19%	18%	41%	20%	22%	20%	19%	17%	23%	22%	34%	28%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	4.65%	11.11%	0.00%	28.00%	31.25%	155.95%	37.21%	-23.73%	1.78%	-34.93%	24.83%
Change in YoY Net Profit Growth (%)	0.00%	6.46%	-11.11%	28.00%	3.25%	124.70%	-118.74%	-60.94%	25.51%	-36.71%	59.77%

Alkyl Amines Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	13%
5 Years:	10%
3 Years:	1%
TTM:	10%

Compounded Profit Growth
10 Years:	15%
5 Years:	0%
3 Years:	-6%
TTM:	26%

Stock Price CAGR
10 Years:	33%
5 Years:	9%
3 Years:	-11%
1 Year:	-3%

Return on Equity
10 Years:	23%
5 Years:	21%
3 Years:	16%
Last Year:	14%

Last Updated: September 4, 2025, 10:50 pm

Balance Sheet

Last Updated: February 1, 2026, 12:20 am

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	10	10	10	10	10	10	10	10	10	10	10	10	10
Reserves	130	165	189	235	287	355	526	782	980	1,159	1,257	1,392	1,433
Borrowings	151	135	111	120	181	165	87	47	23	88	3	6	2
Other Liabilities	98	93	95	147	159	218	160	306	359	335	314	381	322
Total Liabilities	388	402	406	512	637	749	783	1,145	1,371	1,592	1,584	1,789	1,767
Fixed Assets	155	151	187	220	355	376	423	458	629	719	1,089	1,044	1,039
CWIP	3	31	16	35	18	43	45	138	143	352	36	52	76
Investments	2	2	2	1	1	1	-0	30	-0	-0	-0	-0	-0
Other Assets	229	218	201	256	262	328	315	520	600	521	459	693	651
Total Assets	388	402	406	512	637	749	783	1,145	1,371	1,592	1,584	1,789	1,767

Below is a detailed analysis of the balance sheet data for Alkyl Amines Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
For Reserves, as of Sep 2025, the value is 1,433.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,392.00 Cr. (Mar 2025) to 1,433.00 Cr., marking an increase of 41.00 Cr..
For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 6.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 4.00 Cr..
For Other Liabilities, as of Sep 2025, the value is 322.00 Cr.. The value appears to be improving (decreasing). It has decreased from 381.00 Cr. (Mar 2025) to 322.00 Cr., marking a decrease of 59.00 Cr..
For Total Liabilities, as of Sep 2025, the value is 1,767.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,789.00 Cr. (Mar 2025) to 1,767.00 Cr., marking a decrease of 22.00 Cr..
For Fixed Assets, as of Sep 2025, the value is 1,039.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,044.00 Cr. (Mar 2025) to 1,039.00 Cr., marking a decrease of 5.00 Cr..
For CWIP, as of Sep 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 24.00 Cr..
For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
For Other Assets, as of Sep 2025, the value is 651.00 Cr.. The value appears to be declining and may need further review. It has decreased from 693.00 Cr. (Mar 2025) to 651.00 Cr., marking a decrease of 42.00 Cr..
For Total Assets, as of Sep 2025, the value is 1,767.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,789.00 Cr. (Mar 2025) to 1,767.00 Cr., marking a decrease of 22.00 Cr..

Notably, the Reserves (1,433.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	46	61	101	63	102	144	188	364	205	248	275	263
Cash from Investing Activity +	-26	-31	-35	-65	-132	-67	-41	-213	-206	-277	-121	-196
Cash from Financing Activity +	-13	-36	-68	-2	32	-60	-135	-86	-57	8	-140	-49
Net Cash Flow	7	-6	-2	-3	2	17	12	65	-58	-21	13	18

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-66.00	-48.00	-20.00	-25.00	-63.00	-1.00	170.00	383.00	303.00	260.00	249.00	285.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	73	76	68	71	73	66	60	67	66	56	56	54
Inventory Days	133	105	92	165	99	88	67	91	76	82	85	75
Days Payable	79	58	63	120	78	104	57	133	105	84	85	80
Cash Conversion Cycle	128	123	96	116	94	51	71	25	36	53	56	48
Working Capital Days	96	93	87	84	76	56	54	26	35	28	47	42
ROCE %	28%	26%	26%	24%	25%	29%	41%	56%	33%	28%	16%	19%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	71.98%	71.96%	71.96%	71.95%	71.95%	71.97%	71.97%	72.01%	72.04%	72.03%	72.03%	72.03%
FIIs	2.79%	2.86%	2.92%	2.94%	3.04%	3.10%	3.20%	3.23%	3.23%	3.26%	3.44%	3.45%
DIIs	1.15%	1.16%	1.13%	1.07%	1.11%	1.08%	1.53%	1.77%	2.18%	2.60%	2.88%	3.01%
Public	24.08%	24.01%	24.00%	24.05%	23.91%	23.85%	23.31%	23.00%	22.54%	22.11%	21.66%	21.52%
No. of Shareholders	2,03,677	2,01,859	1,99,781	1,97,171	1,92,885	1,87,077	1,79,008	1,74,927	1,68,960	1,61,021	1,53,451	1,49,324

Shareholding Pattern Chart

No. of Shareholders

Alkyl Amines Chemicals Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
HSBC Small Cap Fund	460,300	0.48	72.29	N/A	N/A	N/A
Aditya Birla Sun Life Business Cycle Fund	71,982	0.65	11.31	N/A	N/A	N/A
Aditya Birla Sun Life Manufacturing Equity Fund	57,147	0.85	8.98	N/A	N/A	N/A
ICICI Prudential Commodities Fund	14,952	0.07	2.35	N/A	N/A	N/A
ICICI Prudential Multicap Fund	5,812	0.01	0.91	N/A	N/A	N/A

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	98.71	42.22	32.36	25.41	24.53
Diluted EPS (Rs.)	98.44	42.10	32.36	25.41	24.53
Cash EPS (Rs.)	109.66	51.66	39.53	31.67	30.79
Book Value[Excl.RevalReserv]/Share (Rs.)	262.88	185.71	151.39	125.32	102.02
Book Value[Incl.RevalReserv]/Share (Rs.)	262.88	185.71	151.39	125.32	102.44
Revenue From Operations / Share (Rs.)	486.42	414.66	301.87	245.27	236.92
PBDIT / Share (Rs.)	129.11	81.65	58.94	47.16	45.83
PBIT / Share (Rs.)	115.93	70.22	50.69	40.17	39.51
PBT / Share (Rs.)	118.25	62.98	46.70	36.22	35.58
Net Profit / Share (Rs.)	96.48	40.22	31.28	24.67	24.48
NP After MI And SOA / Share (Rs.)	98.63	42.18	32.33	25.39	24.51
PBDIT Margin (%)	26.54	19.69	19.52	19.23	19.34
PBIT Margin (%)	23.83	16.93	16.79	16.37	16.67
PBT Margin (%)	24.30	15.18	15.47	14.76	15.01
Net Profit Margin (%)	19.83	9.70	10.36	10.05	10.33
NP After MI And SOA Margin (%)	20.27	10.17	10.71	10.35	10.34
Return on Networth / Equity (%)	37.51	22.71	21.35	20.25	24.02
Return on Capital Employeed (%)	37.58	27.83	22.04	22.65	28.29
Return On Assets (%)	25.69	11.29	10.17	9.91	12.03
Long Term Debt / Equity (X)	0.08	0.20	0.35	0.25	0.21
Total Debt / Equity (X)	0.08	0.34	0.48	0.39	0.47
Asset Turnover Ratio (%)	1.28	1.21	1.06	1.08	1.18
Current Ratio (X)	1.91	1.26	1.33	1.40	1.42
Quick Ratio (X)	1.37	0.83	0.85	0.70	0.93
Inventory Turnover Ratio (X)	5.03	5.05	3.29	3.00	3.90
Dividend Payout Ratio (NP) (%)	18.23	16.58	15.45	0.00	40.76
Dividend Payout Ratio (CP) (%)	16.08	13.04	12.31	0.00	32.41
Earning Retention Ratio (%)	81.77	83.42	84.55	0.00	59.24
Cash Earning Retention Ratio (%)	83.92	86.96	87.69	0.00	67.59
Interest Coverage Ratio (X)	25.70	11.29	14.76	11.95	11.64
Interest Coverage Ratio (Post Tax) (X)	18.74	6.56	8.83	7.25	7.22
Enterprise Value (Cr.)	2474.74	1821.38	1383.38	1017.13	733.06
EV / Net Operating Revenue (X)	2.49	2.15	2.25	2.03	1.52
EV / EBITDA (X)	9.39	10.93	11.50	10.56	7.84
MarketCap / Net Operating Revenue (X)	2.48	2.02	2.01	1.84	1.33
Retention Ratios (%)	81.76	83.41	84.54	0.00	59.23
Price / BV (X)	4.58	4.52	4.00	3.60	3.08
Price / Net Operating Revenue (X)	2.48	2.02	2.01	1.84	1.33
EarningsYield	0.08	0.05	0.05	0.05	0.07

After reviewing the key financial ratios for Alkyl Amines Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 20, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 20, the value is 98.71. This value is within the healthy range. It has increased from 42.22 (Mar 19) to 98.71, marking an increase of 56.49.
For Diluted EPS (Rs.), as of Mar 20, the value is 98.44. This value is within the healthy range. It has increased from 42.10 (Mar 19) to 98.44, marking an increase of 56.34.
For Cash EPS (Rs.), as of Mar 20, the value is 109.66. This value is within the healthy range. It has increased from 51.66 (Mar 19) to 109.66, marking an increase of 58.00.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 486.42. It has increased from 414.66 (Mar 19) to 486.42, marking an increase of 71.76.
For PBDIT / Share (Rs.), as of Mar 20, the value is 129.11. This value is within the healthy range. It has increased from 81.65 (Mar 19) to 129.11, marking an increase of 47.46.
For PBIT / Share (Rs.), as of Mar 20, the value is 115.93. This value is within the healthy range. It has increased from 70.22 (Mar 19) to 115.93, marking an increase of 45.71.
For PBT / Share (Rs.), as of Mar 20, the value is 118.25. This value is within the healthy range. It has increased from 62.98 (Mar 19) to 118.25, marking an increase of 55.27.
For Net Profit / Share (Rs.), as of Mar 20, the value is 96.48. This value is within the healthy range. It has increased from 40.22 (Mar 19) to 96.48, marking an increase of 56.26.
For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 98.63. This value is within the healthy range. It has increased from 42.18 (Mar 19) to 98.63, marking an increase of 56.45.
For PBDIT Margin (%), as of Mar 20, the value is 26.54. This value is within the healthy range. It has increased from 19.69 (Mar 19) to 26.54, marking an increase of 6.85.
For PBIT Margin (%), as of Mar 20, the value is 23.83. This value exceeds the healthy maximum of 20. It has increased from 16.93 (Mar 19) to 23.83, marking an increase of 6.90.
For PBT Margin (%), as of Mar 20, the value is 24.30. This value is within the healthy range. It has increased from 15.18 (Mar 19) to 24.30, marking an increase of 9.12.
For Net Profit Margin (%), as of Mar 20, the value is 19.83. This value exceeds the healthy maximum of 10. It has increased from 9.70 (Mar 19) to 19.83, marking an increase of 10.13.
For NP After MI And SOA Margin (%), as of Mar 20, the value is 20.27. This value exceeds the healthy maximum of 20. It has increased from 10.17 (Mar 19) to 20.27, marking an increase of 10.10.
For Return on Networth / Equity (%), as of Mar 20, the value is 37.51. This value is within the healthy range. It has increased from 22.71 (Mar 19) to 37.51, marking an increase of 14.80.
For Return on Capital Employeed (%), as of Mar 20, the value is 37.58. This value is within the healthy range. It has increased from 27.83 (Mar 19) to 37.58, marking an increase of 9.75.
For Return On Assets (%), as of Mar 20, the value is 25.69. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.69, marking an increase of 14.40.
For Long Term Debt / Equity (X), as of Mar 20, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 19) to 0.08, marking a decrease of 0.12.
For Total Debt / Equity (X), as of Mar 20, the value is 0.08. This value is within the healthy range. It has decreased from 0.34 (Mar 19) to 0.08, marking a decrease of 0.26.
For Asset Turnover Ratio (%), as of Mar 20, the value is 1.28. It has increased from 1.21 (Mar 19) to 1.28, marking an increase of 0.07.
For Current Ratio (X), as of Mar 20, the value is 1.91. This value is within the healthy range. It has increased from 1.26 (Mar 19) to 1.91, marking an increase of 0.65.
For Quick Ratio (X), as of Mar 20, the value is 1.37. This value is within the healthy range. It has increased from 0.83 (Mar 19) to 1.37, marking an increase of 0.54.
For Inventory Turnover Ratio (X), as of Mar 20, the value is 5.03. This value is within the healthy range. It has decreased from 5.05 (Mar 19) to 5.03, marking a decrease of 0.02.
For Dividend Payout Ratio (NP) (%), as of Mar 20, the value is 18.23. This value is below the healthy minimum of 20. It has increased from 16.58 (Mar 19) to 18.23, marking an increase of 1.65.
For Dividend Payout Ratio (CP) (%), as of Mar 20, the value is 16.08. This value is below the healthy minimum of 20. It has increased from 13.04 (Mar 19) to 16.08, marking an increase of 3.04.
For Earning Retention Ratio (%), as of Mar 20, the value is 81.77. This value exceeds the healthy maximum of 70. It has decreased from 83.42 (Mar 19) to 81.77, marking a decrease of 1.65.
For Cash Earning Retention Ratio (%), as of Mar 20, the value is 83.92. This value exceeds the healthy maximum of 70. It has decreased from 86.96 (Mar 19) to 83.92, marking a decrease of 3.04.
For Interest Coverage Ratio (X), as of Mar 20, the value is 25.70. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.70, marking an increase of 14.41.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is 18.74. This value is within the healthy range. It has increased from 6.56 (Mar 19) to 18.74, marking an increase of 12.18.
For Enterprise Value (Cr.), as of Mar 20, the value is 2,474.74. It has increased from 1,821.38 (Mar 19) to 2,474.74, marking an increase of 653.36.
For EV / Net Operating Revenue (X), as of Mar 20, the value is 2.49. This value is within the healthy range. It has increased from 2.15 (Mar 19) to 2.49, marking an increase of 0.34.
For EV / EBITDA (X), as of Mar 20, the value is 9.39. This value is within the healthy range. It has decreased from 10.93 (Mar 19) to 9.39, marking a decrease of 1.54.
For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
For Retention Ratios (%), as of Mar 20, the value is 81.76. This value exceeds the healthy maximum of 70. It has decreased from 83.41 (Mar 19) to 81.76, marking a decrease of 1.65.
For Price / BV (X), as of Mar 20, the value is 4.58. This value exceeds the healthy maximum of 3. It has increased from 4.52 (Mar 19) to 4.58, marking an increase of 0.06.
For Price / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
For EarningsYield, as of Mar 20, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 19) to 0.08, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Alkyl Amines Chemicals Ltd as of March 27, 2026 is: ₹1,240.77

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 27, 2026, Alkyl Amines Chemicals Ltd is Overvalued by 9.96% compared to the current share price ₹1,378.00

Intrinsic Value of Alkyl Amines Chemicals Ltd as of March 27, 2026 is: ₹1,187.27

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 27, 2026, Alkyl Amines Chemicals Ltd is Overvalued by 13.84% compared to the current share price ₹1,378.00

Last 5 Year EPS CAGR: -4.31%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 29.25%, which is a positive sign. The company has higher reserves (683.85 cr) compared to borrowings (86.08 cr), indicating strong financial stability. The company has shown consistent growth in sales (336.00 cr) and profit (189.92 cr) over the years.	The stock has a high average Working Capital Days of 60.33, which may not be favorable. The stock has a high average Cash Conversion Cycle of 74.75, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alkyl Amines Chemicals Ltd:
1. Net Profit Margin: 19.83%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 37.58% (Industry Average ROCE: 13.78%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 37.51% (Industry Average ROE: 9.96%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 18.74
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.37
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 39 (Industry average Stock P/E: 140.9)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.08
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Alkyl Amines Chemicals Ltd. is a Public Limited Listed company incorporated on 17/10/1979 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1979PLC021796 and registration number is 021796. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 1571.82 Cr. and Equity Capital is Rs. 10.24 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Organic - Others	401-407, Nirman Vyapar Kendra, Plot No. 10, Sector 17, New Mumbai Maharashtra 400703	Contact not found

Management
Name	Position Held
Mr. Yogesh M Kothari	Chairman & Managing Director
Mr. Kirat M Patel	Executive Director
Mr. Suneet Y Kothari	Executive Director
Mr. Premal N Kapadia	Non Executive Director
Mr. Rakesh S Goyal	Whole-Time Director (Operations)
Mrs. Leja S Hattiangadi	Independent Director
Mr. Chandrashekhar R Gupte	Independent Director
Mr. Ravi B Kapoor	Independent Director
Mr. Ashwin Ramanathan	Independent Director
Mrs. Bhavna G Doshi	Independent Director

FAQ

What is the intrinsic value of Alkyl Amines Chemicals Ltd?

Alkyl Amines Chemicals Ltd's intrinsic value (as of 27 March 2026) is ₹1187.27 which is 13.84% lower the current market price of ₹1,378.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹7,049 Cr. market cap, FY2025-2026 high/low of ₹2,449/1,212, reserves of ₹1,433 Cr, and liabilities of ₹1,767 Cr.

What is the Market Cap of Alkyl Amines Chemicals Ltd?

The Market Cap of Alkyl Amines Chemicals Ltd is 7,049 Cr..

What is the current Stock Price of Alkyl Amines Chemicals Ltd as on 27 March 2026?

The current stock price of Alkyl Amines Chemicals Ltd as on 27 March 2026 is ₹1,378.

What is the High / Low of Alkyl Amines Chemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Alkyl Amines Chemicals Ltd stocks is ₹2,449/1,212.

What is the Stock P/E of Alkyl Amines Chemicals Ltd?

The Stock P/E of Alkyl Amines Chemicals Ltd is 39.0.

What is the Book Value of Alkyl Amines Chemicals Ltd?

The Book Value of Alkyl Amines Chemicals Ltd is 282.

What is the Dividend Yield of Alkyl Amines Chemicals Ltd?

The Dividend Yield of Alkyl Amines Chemicals Ltd is 0.73 %.

What is the ROCE of Alkyl Amines Chemicals Ltd?

The ROCE of Alkyl Amines Chemicals Ltd is 18.7 %.

What is the ROE of Alkyl Amines Chemicals Ltd?

The ROE of Alkyl Amines Chemicals Ltd is 14.0 %.

What is the Face Value of Alkyl Amines Chemicals Ltd?

The Face Value of Alkyl Amines Chemicals Ltd is 2.00.